Hyderabad, India-based Aurobindo Pharma will acquire seven branded oncology injectables from Henderson, Nevada-based Spectrum Pharmaceuticals Inc., for about $300 million. Acrotech Biopharma LLC, a wholly-owned subsidiary of Aurobindo Pharma USA Inc., will acquire the assets. The transaction is expected to close within 90 days. The acquisition involves an upfront payment of...